VoxCell appoints Chief Commercial Officer as Demand Grows for Predictive, Human-Relevant, Non-Clinical Testing Approaches

VoxCell, a Canadian biotechnology company advancing high-resolution, vascularized 3D tissue models, today announced the appointment of Graham Craig as Chief Commercial Officer (CCO). The hire comes as the company sets its sights on growth driven by increasing demand for predictive, human-relevant non-clinical models. VoxCell’s vascularized 3D tissue models replicate key features of the human vascular […]

AstraZeneca Acquires Global Rights to Liver Cancer Treatment

AbelZeta, a clinical-stage biopharmaceutical company developing cell-based therapeutic products, announced, that AstraZeneca had acquired the remaining rights to develop, manufacture, and commercialize C-CAR031, a CAR-T therapy currently being investigated for the treatment of hepatocellular carcinoma (HCC) and other solid tumors. According to a company press release, AstraZeneca will pay up to $630 million in upfront […]

Kindeva Announces Leadership Transition to Drive Strategic Growth

Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the company for accelerating growth in its core businesses focused on parenteral and inhaled drug delivery. Effective January 1, 2026, David Stevens, most recently President at Kindeva, has assumed the role of […]

Vetter Reaches Key Launch Milestones for the V-OVS® next Tamper-Evident Syringe Closure System

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has completed several important steps in the ongoing development and upcoming launch of V-OVS® next. Developed from extensive market feedback, this new closure system will feature several important updates: intuitive handling, innovative functionality and a premium design, that fits a wide range of syringe formats. […]

Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals

Rakuten Medical, Inc. and LOTTE Biologics announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P. Morgan Healthcare Conference in San Francisco to strengthen Rakuten Medical’s production capabilities for its innovative oncology therapy, Alluminox® platform-based photoimmunotherapy. Under the agreement, LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates, […]

Bayer Acquires Investigational Imaging Agents from Attralus

Bayer announced plans to acquire two investigational imaging agents from Attralus, a clinical-stage biopharmaceutical company, on January 12th, 2026. Both agents are being investigated as diagnostic tools for cardiac amyloidosis, a spectrum of diseases caused by the abnormal build-up of amyloid in the heart tissue. Financial details of the transaction were not disclosed in the […]

Sartorius expands bio-circular product offering for more sustainable bioprocesses

Further production hubs in Germany and Tunisia now certified by International Sustainability and Carbon Certification Certified raw materials significantly reduce dependence on fossil-based plastics Bio-circular filters and additional single-use fluid management technologies now available for biopharma manufacturers Certified production network spans sites in Germany, Tunisia, France and the UK   Sartorius is expanding its bio-based […]

Symeres welcomes Jurgen Berendsen as Chief Financial Officer to support next phase of growth

Symeres, a leading contract research, development, and manufacturing organisation (CRDMO), has announced the appointment of Jurgen Berendsen as Chief Financial Officer (CFO), marking a significant return to the company after a successful tenure as Senior Group Controller. Berendsen brings more than 15 years of financial leadership experience across both professional services and international trade sectors, […]

HAS Healthcare Advanced Synthesis SA Group Announces Strategic Investment Plan to Strengthen Leadership in CDMO and ADC Manufacturing

The HAS Healthcare Advanced Synthesis SA Group, formed through last year’s combination of HAS and Cerbios, is approaching the close of its first year as an integrated organization, achieving strong and solid results and a clear path toward expansion. This milestone marks a significant step in the company’s resilient journey of transformation and growth, focused […]